Abstract | BACKGROUND: OBJECTIVES: The aim of the study was to evaluate the effect of an additional daily intake of 400 mg of EPA + DHA and 2 g of ALA on CVD morbidity and mortality in free-living subjects with a history of myocardial infarction. DESIGN: The multicenter Alpha Omega Trial is a randomized, double-blind, placebo-controlled trial with a 2 x 2 factorial design. Between May 2002 and December 2006, we enrolled a total of 4,837 men and women aged 60 through 80 who experienced a myocardial infarction within 10 years before entering the study. Subjects were randomized to 1 of 4 margarine spreads that were enriched with EPA + DHA and/or ALA, or placebo. Compliance was monitored via tub counts and assessment of n-3 fatty acids in plasma. Subjects were observed for 40 months for the occurrence of fatal and nonfatal CVD. RESULTS: The cohort was on average 69 years old at the start of the study and comprised 22% women. Subjects had their (last) myocardial infarction approximately 4 years before enrollment. Mean body mass index was 27.7 kg/m(2), and 17% smoked. Average serum total and high-density lipoprotein cholesterol were 4.7 and 1.3 mmol/L, respectively, and 85% used statins. Mean blood pressure was 142/80 mm Hg, and most subjects were on antihypertensive medication (88%). Diabetes mellitus was reported by 17% of the subjects, and 7% reported a history of stroke. The overall mortality rate during the trial period was 23 per 1,000 person-years, with approximately 40% due to CVD. CURRENT STATUS: Follow-up of the patients was completed in November 2009, and findings will be reported in the second part of 2010.
|
Authors | Johanna M Geleijnse, Erik J Giltay, Evert G Schouten, Janette de Goede, Linda M Oude Griep, Anna M Teitsma-Jansen, Martijn B Katan, Daan Kromhout, Alpha Omega Trial Group |
Journal | American heart journal
(Am Heart J)
Vol. 159
Issue 4
Pg. 539-546.e2
(Apr 2010)
ISSN: 1097-6744 [Electronic] United States |
PMID | 20362710
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 Mosby, Inc. All rights reserved. |
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Cardiovascular Diseases
(drug therapy, mortality, prevention & control)
- Double-Blind Method
- Fatty Acids, Omega-3
(pharmacology)
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(drug therapy)
- Risk Factors
- Treatment Outcome
|